Suxamethonium-induced	suxamethonium-induced	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrest	arrest	O	DISEASE	OTHERS	I
and	and	O	O	O	O
death	death	O	DISEASE	OTHERS	I
following	following	O	O	O	O
5	5	O	O	O	O
days	days	O	O	O	O
of	of	O	O	O	O
immobilization	immobilization	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
present	present	O	O	O	O
report	report	O	O	O	O
describes	describes	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrest	arrest	O	DISEASE	OTHERS	I
and	and	O	O	O	O
subsequent	subsequent	O	O	O	O
death	death	O	DISEASE	OTHERS	I
as	as	O	O	O	O
a	a	O	O	O	O
result	result	O	O	O	O
of	of	O	O	O	O
hyperkalaemia	hyperkalaemia	O	O	OTHERS	I
following	following	O	O	O	O
the	the	O	O	O	O
use	use	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
23-year-old	23-year-old	O	O	O	O
Malawian	malawian	O	O	O	O
woman	woman	O	O	O	O
.	.	O	O	O	O

Five	five	O	O	O	O
days	days	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
onset	onset	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
symptoms	symptoms	O	O	O	O
of	of	O	O	O	O
meningitis	meningitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
aspirated	aspirated	O	O	O	O
stomach	stomach	O	O	O	O
contents	contents	O	O	O	O
and	and	O	O	O	O
needed	needed	O	O	O	O
endotracheal	endotracheal	O	O	O	O
intubation	intubation	O	O	O	O
.	.	O	O	O	O

Forty	forty	O	O	O	O
seconds	seconds	O	O	O	O
after	after	O	O	O	O
injection	injection	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
arrest	arrest	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
.	.	O	O	O	O

Attempts	attempts	O	O	O	O
to	to	O	O	O	O
resuscitate	resuscitate	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
successful	successful	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
serum	serum	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
potassium	potassium	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
observed	observed	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
8.4	8.4	O	O	O	O
mequiv	mequiv	O	O	O	O
L-1	l-1	O	O	O	O
.	.	O	O	O	O

Apart	apart	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
reduction	reduction	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
's	's	O	O	O	O
level	level	O	O	O	O
of	of	O	O	O	O
consciousness	consciousness	O	O	O	O
,	,	O	O	O	O
there	there	O	O	O	O
were	were	O	O	O	O
no	no	O	O	O	O
signs	signs	O	O	O	O
of	of	O	O	O	O
motor	motor	O	O	O	O
neurone	neurone	O	O	O	O
damage	damage	O	O	O	O
or	or	O	O	O	O
of	of	O	O	O	O
any	any	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
known	known	O	O	O	O
predisposing	predisposing	O	O	O	O
conditions	conditions	O	O	O	O
for	for	O	O	O	O
hyperkalaemia	hyperkalaemia	O	O	OTHERS	I
following	following	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

It	it	O	O	O	O
is	is	O	O	O	O
postulated	postulated	O	O	O	O
that	that	O	O	O	O
her	her	O	O	O	O
death	death	O	DISEASE	OTHERS	I
was	was	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
hypersensitivity	hypersensitivity	O	DISEASE	OTHERS	I
to	to	O	O	O	O
suxamethonium	suxamethonium	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
her	her	O	O	O	O
5-day	5-day	O	O	O	O
immobilization	immobilization	O	O	O	O
.	.	O	O	O	O

